WuXi Biologics

WXXWY

11.9702.84% ( -0.350 )

Delay Closed: Nov 13, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is 34.09, within the reasonable range, cheaper than 21.05% of the time in the past 3 years, and the industry ranks 11/58, the industry Median -1.37.

34.09xP/E

Stock price$11.97Earnings per share$0.35

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x40x80x120x160x200x

P/E ratio
Name/Symbol
TMOUSThermo Fisher Scentific	36.69x	10.09%	$259.44B
DHRUSDanaher	37.85x	24.55%	$163.94B
AUSAgilent Tech	34.06x	12.30%	$49.04B
IQVUSIQVIA	31.34x	2.27%	$43.69B
MTDUSMettler Toledo	37.03x	11.26%	$34.59B
ILMNUSIllumina	34.97x	7.16%	$31.30B
WXXWYUSWuXi Biologics	34.09x	--	$24.56B
MEDPUSMedpace	35.32x	19.31%	$18.29B
ICLRUSICON	33.65x	109.30%	$14.58B
AVTRUSAvantor	31.23x	169.57%	$10.53B
QGENUSQiagen NV	26.76x	7.60%	$10.30B
SHCUSSotera Health	27.35x	145.37%	$4.74B
STVNUSStevanato Group SpA	26.76x	2.73%	$4.32B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.